Centre doesn’t endorse Biocon drug for Covid
Biocon suffered a setback on Sunday with the Union health ministry announcing that the firm’s itolizumab drug has not been included in national treatment protocol for Covid-19 patients.
Maharashtra govt may continue capping of hospital charges till November-